Find Stocks to Buy in July that are Gaining More Attention on Wall StreetZacks Investment Research • 06/27/23
Wall Street Analysts See a 44.32% Upside in Ligand (LGND): Can the Stock Really Move This High?Zacks Investment Research • 06/16/23
Is Ligand Pharmaceuticals (LGND) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/09/23
Wall Street Analysts Think Ligand (LGND) Could Surge 44.42%: Read This Before Placing a BetZacks Investment Research • 05/24/23
Ligand's Partner Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)Business Wire • 05/16/23
Wall Street Analysts Believe Ligand (LGND) Could Rally 38.66%: Here's is How to TradeZacks Investment Research • 05/08/23
Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/04/23